6160 — BeOne Medicines AG Cashflow Statement
0.000.00%
Last trade - 00:00- HK$294.52bn
- HK$271.65bn
- CNY27.21bn
- 63
- 5
- 100
- 60
Annual cashflow statement for BeOne Medicines AG, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | CAS | CAS | CAS | CAS | CAS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -237 | -7,254 | -9,674 | -12,843 | -14,880 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5,180 | -8,285 | -7,800 | -7,793 | -1,259 |
| Capital Expenditures | -992 | -2,256 | -2,335 | -4,106 | -3,418 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -20,864 | 5,389 | 4,749 | 4,223 | 1,030 |
| Acquisition of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -21,856 | 3,133 | 2,415 | 117 | -2,389 |
| Financing Cash Flow Items | 29,415 | 22,401 | 146 | 172 | -167 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31,370 | 22,867 | -448 | 2,558 | 826 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4,244 | 17,674 | -5,764 | -5,073 | -2,841 |